For the year 2000 it has been estimated that some 564,000 new cases of PLC occurred
worldwide, corresponding to 398,364 in men and 165,972 in women. Table 1 presents the …

Worldwide, hepatitis B virus (HBV) is the most common among those hepatitis viruses that
cause chronic infections of the liver in humans, and it represents a global public health …

Estimates of the worldwide incidence, mortality and prevalence of 26 cancers in the year
2002 are now available in the GLOBOCAN series of the International Agency for Research …

Background Limited data are available regarding global hepatitis B virus (HBV)-related
morbidity and mortality and potential reduction in disease burden from hepatitis B …

Hepatitis B is one of the most common infectious diseases globally. It has been estimated
that there are 350 million chronic hepatitis B virus (HBV) carriers worldwide. The prevalence …

Background: The Diabetes Prevention Program (DPP) demonstrated that interventions can
delay or prevent the development of type 2 diabetes. Objective: To estimate the lifetime cost …

Hepatocellular carcinoma (HCC) is responsible for a large proportion of cancer deaths
worldwide. HCC is frequently diagnosed after the development of clinical deterioration at …

Hepatocellular carcinoma (HCC) is a major contributor to cancer incidence and mortality.
There is a wide variation, however, in the global distribution of HCC. Eighty percent of the …

Abstract Knowledge of the incidence of cancer is a fundamental requirement of rational
planning and monitoring of cancer control programs. The lack of national-level information …

Many common cancers develop as a consequence of years of chronic inflammation.
Increasing evidence indicates that the inflammation may result from persistent mucosal or …